To gain further insights into the mechanisms of sensitivity and resistance to TAK-243, we conducted a genome-wide CRISPR/Cas9 knockout screen in AML cells and identified the transcriptional repressor BEN domain-containing protein 3 (BEND3) as the top gene whose knockout confers resistance to TAK-243. Here, BEND3 is linked to acute myeloid leukemia.